Evidence map›Paper›PMID 39705382›Full record

Trial reportJournal of patient safety2025

Older Adult Misuse of Over-the-Counter Medications: Effectiveness of a Novel Pharmacy-Based Intervention to Improve Patient Safety.

Aaron M Gilson, Jason S Chladek, Jamie A Stone, Taylor L Watterson, Elin C Lehnbom, Emily L Hoffins, Maria E Berbakov, Jukrin Moon, Nora A Jacobson, Richard J Holden and 8 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of patient safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jason S ChladekFrom the Division of Social and Administrative Sciences.
Jamie A Stone
Taylor L WattersonDepartment of Pharmacy Systems, Outcomes, and Policy, University of Illinois Chicago College of Pharmacy, Chicago, Illinois.
Elin C Lehnbom
Emily L HoffinsFrom the Division of Social and Administrative Sciences.
Maria E Berbakov
Jukrin Moon
Nora A JacobsonInstitute for Clinical and Translational Research, Community Academic Partnerships Program, University of Wisconsin-Madison, Madison, Wisconsin.
Richard J HoldenIndiana University School of Medicine, Indianapolis, Indiana.
Ronald E Gangnon
Denise L Walbrandt Pigarelli
Lauren L Welch
Edward C Portillo
Olayinka O ShiyanbolaFrom the Division of Social and Administrative Sciences.
Joel GollhardtAurora Pharmacy, Wautoma.
Kenneth WalkerAurora Pharmacy, Depere, Wisconsin.

Funding

University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
NRSA Training CoreTL1TR002375 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI Vivek Prabhakaran · 2017 to 2026
$8.4M
AHRQ HHS R18 HS027737NCATS NIH HHS TL1 TR002375NCATS NIH HHS UL1 TR002373
6 · The paper itself

Abstract

objectivesOlder adults' (ages ≥65) inappropriate over-the-counter medications (OTC) use is prevalent, comprising Drug-Age, Drug-Drug, Drug-Disease, and Drug-Label types. Given that pharmacies sell many OTCs, structurally redesigning pharmacy aisles for improving patient safety (Senior Safe) was conceived to mitigate older adult OTC misuse, using Stop Signs and Behind-the-Counter Signs for high-risk OTCs. This study determined whether Senior Safe reduced high-risk OTCs misuse, while secondarily evaluating misuse changes for all OTCs.

methodsA randomized controlled trial design matched and randomly allocated 20 health system community pharmacies to control or intervention groups. All 288 study participants completed an OTC choice task in which they chose a hypothetical symptom scenario (pain, sleep, cough/cold/allergy), selected an OTC, and described how they would use it at symptom onset and if symptoms persisted or worsened. Reported OTC use was evaluated for each misuse type. Intervention and control sites were compared for each misuse type using multivariate modeling.

resultsFor high-risk OTCs, Drug-Age and Drug-Drug misuse were more likely in control sites (OR = 2.752, P = 0.004; OR = 6.199, P = 0.003, respectively), whereas Drug-Disease and Drug-Label misuse had too few occurrences in intervention sites for statistical comparisons. For all OTCs, only Drug-Age misuse was more likely for control sites (OR = 5.120, P = 0.001). Adults aged 85+ years had the greatest likelihood of all misuse types.

conclusionsResults demonstrated that older adults frequently reported multiple misuse types, highlighting safety concerns. Senior Safe reduced high-risk OTC misuse, especially for older adults younger than 85 years. Cumulatively, these findings provide insights into practice recommendations supported through regulatory guidance.

Indexed as

Nonprescription DrugsPatient SafetyAgedAged, 80 and overCommunity Pharmacy ServicesFemaleHumansMaleNonprescription Drugs

Identifiers

PMID39705382
PMCPMC12243473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.